STOCK TITAN
  1. Home
  2. Sec-filings
  3. NUTX
  4. [Form 4] Nutex Health Inc. Insider Trading Activity

Nutex Health (NUTX) director gains 603 shares via restricted stock unit conversion

Filing Impact
(Neutral)
Filing Sentiment
(Neutral)
Form Type
4

Rhea-AI Filing Summary

Nutex Health Inc. director Scott J. Saunders acquired 603 shares of common stock on 2026-07-31 through the conversion of restricted stock units, which convert into common stock on a one-for-one basis. The shares were acquired at $0.0000 per share and are held directly, totaling 603 shares.

Positive

  • None.

Negative

  • None.
Insider Saunders Scott J
Role Director
Type Security Shares Price Value
Exercise Common Stock F1 603 $0.00 $0.00
Holdings After Transaction: Common Stock — 603 shares (Direct)
Footnotes (1)
  1. F1. Restricted stock units convert into common stock on a one-for-one basis.
Shares acquired 603.0000 shares Common stock acquired via restricted stock unit conversion on 2026-07-31
Price per share $0.0000 Stated acquisition price per share for the RSU conversion
Shares owned after transaction 603.0000 shares Total Nutex Health common shares directly owned after the reported transaction
Transaction date 2026-07-31 Date of restricted stock unit conversion into common stock
Restricted stock units financial
"Restricted stock units convert into common stock on a one-for-one basis."
Restricted stock units are a type of company reward where employees are promised shares of stock, but they only fully own these shares after meeting certain conditions, like staying with the company for a set time. They matter because they can become valuable assets and are often used to motivate employees to help the company succeed.
derivative security financial
"transaction_code_description: Exercise or conversion of derivative security"
A derivative security is a financial contract whose value comes from the price or performance of something else, such as a stock, bond, commodity, or market index. For investors it acts like an insurance policy or a wager: it can be used to protect against losses, lock in prices, or amplify gains and losses, so it can change a portfolio’s risk and potential return without owning the underlying asset directly.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google
Add on Google
Form 4 Insider Transactions: What Each Field Means →

FAQ

What insider transaction did Nutex Health (NUTX) director Scott J. Saunders report?
Scott J. Saunders acquired 603 shares of Nutex Health common stock on 2026-07-31 through conversion of restricted stock units. The RSUs convert into common stock on a one-for-one basis, and these shares are now held directly at a stated price of $0.0000 per share.

How many Nutex Health (NUTX) shares were acquired in the reported Form 4 transaction?
The transaction shows an acquisition of 603 shares of Nutex Health common stock. These shares resulted from the conversion of restricted stock units into common stock on a one-for-one basis, rather than an open-market purchase, and are now recorded as directly owned by the director.

What does the restricted stock units footnote mean for Nutex Health (NUTX) in this filing?
The footnote explains that the restricted stock units convert into Nutex Health common stock on a one-for-one basis. This means each vested RSU delivered one share of common stock, resulting in 603 new directly held shares without a cash purchase price in this transaction.

What is Scott J. Saunders’ Nutex Health (NUTX) share ownership after this transaction?
After the transaction, Scott J. Saunders directly owns 603 shares of Nutex Health common stock. The reported holdings equal the number of shares acquired in this RSU conversion, indicating these are the total directly held common shares following the reported activity on 2026-07-31.

Was the Nutex Health (NUTX) insider transaction reported under a Rule 10b5-1 trading plan?
The Rule 10b5-1 checkbox for this insider report was not marked as an affirmative trading plan. As a result, the disclosure does not state that this RSU conversion transaction occurred pursuant to a pre-arranged Rule 10b5-1 trading plan for the reporting person.
SEC Form 4
FORM 4UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number:3235-0287
Estimated average burden
hours per response:0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
1. Name and Address of Reporting Person*
Saunders Scott J
(Last)(First)(Middle)
1776 YORKTOWN STREET SUITE 700
C/O NUTEX HEALTH INC.
(Street)
HOUSTON TEXAS 77056
(City)(State)(Zip)
UNITED STATES
(Country)		2. Issuer Name and Ticker or Trading Symbol
Nutex Health Inc. [ NUTX ] 		5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
XDirector10% Owner
Officer (give title below)Other (specify below)
2a. Foreign Trading Symbol
3. Date of Earliest Transaction (Month/Day/Year)
07/31/2026		6. Individual or Joint/Group Filing (Check Applicable Line)
XForm filed by One Reporting Person
Form filed by More than One Reporting Person
4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year)2A. Deemed Execution Date, if any (Month/Day/Year)3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeVAmount(A) or (D)Price
Common Stock07/31/2026M603A$0(1)603D
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year)3A. Deemed Execution Date, if any (Month/Day/Year)4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year)7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeV(A)(D)Date ExercisableExpiration DateTitleAmount or Number of Shares
Explanation of Responses:
1. Restricted stock units convert into common stock on a one-for-one basis.
/s/ Scott J. Saunders08/03/2026
** Signature of Reporting PersonDate
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)

Source: View Original Filing on SEC EDGAR